Dropout Rate for Taking Sovaldi: 400% Higher Than Observed in Clinical Trials
Learn about the financial impact for Hep C patients who are failing to complete their full, 12-week course of drug therapy with Sovaldi.
Continue reading »Learn about the financial impact for Hep C patients who are failing to complete their full, 12-week course of drug therapy with Sovaldi.
Continue reading »Many factors – including the country you live in – influence who will be able to pay for the top Hepatitis C medication.
Continue reading »Dependent on the factor of time, simultaneously having more than one hepatitis infection might accelerate liver disease or it could help scientists develop a Hepatitis C vaccine.
Continue reading »The new drug from Gilead could reach upwards of $95,000 - $100,000; but learn why Gilead expects savings for some patients in its pricing scheme.
Continue reading »New findings emerge that shed light on how long patients may need to be treated with telaprevir in order to achieve viral eradication.
Continue reading »Approved by the FDA as a medication for use in combination with peginterferon alfa and ribavirin to treat chronic Hepatitis C genotype 1 - Incivek will no longer be sold since better medications have become available.
Continue reading »Understand the circumstances dictating why a sustained virologic response for Hepatitis C could be temporary or permanent.
Continue reading »By breaking the replication cycle of Hepatitis C, a new health benefit of pomegranate has been confirmed.
Continue reading »Meet HCV expert Aijad Ahmed, MD in this webinar series sponsored by the American Liver Foundation and Chronic Liver Disease Foundation.
Continue reading »When a son or daughter has Hepatitis C, telling them about it is hard. These pointers can help guide parents or guardians towards having “tough” disclosure conversations in a way that benefits the child most.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window